shopify analytics ecommerce
tracking

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD

By Pakka Admin - Sep 18,2019

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD

Join UCLA oncologist Gottfried Konecny, MD, for an overview of the PARP inhibitors olaparib, niraparib, and rucaparib, which have been approved for the treatment of ovarian cancers and how to proactively plan for and manage treatment-related toxicities. #UCLAMDChat

Related Videos

Endometriosis
Dec,13 2019 05:53 PM

Endometriosis